Post-Merger Integration for Life Sciences

Publish date:

Realizing synergies and maximizing value through post-merger integration. Another wave of consolidation is hitting the life sciences industry. In 2009, a combination of mega-mergers, diversification plays and tuck-in acquisitions have characterized the merger and acquisition (M&A) landscape in the pharmaceutical sector. The trend is expected to continue as CEOs respond to industry pressures and opportunities […]

Realizing synergies and maximizing value through post-merger integration.

Another wave of consolidation is hitting the life sciences industry. In 2009, a combination of mega-mergers, diversification plays and tuck-in acquisitions have characterized the merger and acquisition (M&A) landscape in the pharmaceutical sector. The trend is expected to continue as CEOs respond to industry pressures and opportunities to create value through M&A and divestitures. However, it is still unclear whether these transactions ever fulfill the value they promise.

Related Resources

Exploring new revenue opportunities in 5G

5G networks offer more bandwidth, better latency, and improved reliability. Those...

Competing in the age of customer-centric grocery

The Grocery and Mass Merchandise is in the midst of an intense, prolonged period of...

Data Mastery

Become a Data Master with Capgemini’s Applied Innovation Exchange